Portfolio (Quarterly)
Guide ↗
Privium Fund Management B.V.
· CIK 0001795097| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 320,972.0 | $7.6M | 1.57% | +15K | +4.9% | $23.56 | +7.3% |
| 22 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 92,305.0 | $5.2M | 1.09% | NEW | — | $56.49 | +13.0% |
| 23 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 11,355.0 | $5.1M | 1.06% | +2K | +21.4% | $446.54 | +11.1% |
| 24 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 254,857.0 | $4.9M | 1.02% | NEW | — | $19.20 | +29.3% |
| 25 | URGN | UROGEN PHARMA LTD | Healthcare | 238,122.0 | $4.3M | 0.89% | +24K | +10.9% | $17.98 | +161.2% |
| 26 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 12,222.0 | $4.0M | 0.84% | NEW | — | $330.87 | -33.8% |
| 27 | VRDN | VIRIDIAN THERAPEUTICS INC | Healthcare | 173,516.0 | $3.4M | 0.71% | — | — | $19.56 | +20.6% |
| 28 | KRYS | KRYSTAL BIOTECH INC | Healthcare | 11,170.0 | $2.9M | 0.60% | -1K | -8.2% | $258.32 | +26.4% |
| 29 | ABEV | AMBEV SA | Consumer Defensive | 948,558.0 | $2.8M | 0.58% | -115K | -10.8% | $2.92 | +2.7% |
| 30 | ZLAB | ZAI LAB LTD | Healthcare | 132,189.0 | $2.5M | 0.52% | — | — | $18.81 | +24.0% |
| 31 | BNTX | BIONTECH SE | Healthcare | 27,000.0 | $2.4M | 0.50% | -6K | -18.9% | $88.88 | +5.4% |
| 32 | — | ENGENE HOLDINGS INC | — | 352,087.0 | $2.4M | 0.50% | — | — | $6.81 | — |
| 33 | CRSP | CRISPR THERAPEUTICS AG | Healthcare | 42,874.0 | $2.0M | 0.42% | — | — | $47.57 | +12.5% |
| 34 | MGTX | MEIRAGTX HLDGS PLC | Healthcare | 212,112.0 | $1.8M | 0.38% | +12K | +6.1% | $8.66 | +50.9% |
| 35 | WVE | WAVE LIFE SCIENCES LTD | Healthcare | 241,010.0 | $1.7M | 0.36% | +48K | +24.9% | $7.25 | -15.9% |
| 36 | STOK | STOKE THERAPEUTICS INC | Healthcare | 50,000.0 | $1.6M | 0.34% | -5K | -9.1% | $32.56 | +0.5% |
| 37 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 170,256.0 | $1.6M | 0.33% | -40K | -18.9% | $9.31 | +15.5% |
| 38 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 63,982.0 | $1.5M | 0.32% | -8K | -10.5% | $23.83 | +15.3% |
| 39 | MRNA | MODERNA INC | Healthcare | 29,994.0 | $1.5M | 0.32% | -20K | -39.5% | $50.80 | +16.5% |
| 40 | PFE | PFIZER INC | Healthcare | 52,679.0 | $1.5M | 0.31% | +15K | +39.5% | $28.08 | -4.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
33.5%
Consumer Cyclical
25.1%
Technology
24.3%
Financial Services
8.5%
Communication Services
6.8%
Energy
0.8%
Consumer Defensive
0.6%
Basic Materials
0.3%